期刊文献+

1遍ELISA+1遍NAT血液筛查模式的应用研究 被引量:7

Research on application of blood screening testing method:one round NAT combined with one round serological test
下载PDF
导出
摘要 目的通过对比开展"1遍ELISA+1遍NAT血液筛查"新模式前后HBsAg、抗-HCV和抗-HIV的反应性比率,比较新旧2种筛查方法检测结果的符合率,探讨新模式的应用效果。方法 2013年1月1日~6月13日青岛市中心血站采用2遍ELISA 1遍NAT筛查了42 147例标本,6月14日~12月31日采用1遍ELISA 1遍NAT筛查了55 924例标本,比较采用新模式前后HBsAg、抗-HCV和抗-HIV的反应性比率,分析新模式中反应性标本在ELISA和NAT中的符合率。结果 1遍ELISA的HBsAg和抗-HCV反应性比率与2遍相比较,差异无显著统计学意义(P〉0.05);而抗-HIV的反应性比率明显低于2遍ELISA模式,差异有统计学意义(P〈0.05),抗-HIV的假阳性率为75%。采用1遍ELISA共检测出HBsAg、抗-HCV和抗-HIV ELISA反应性标本217例,3者的强反应性标本(OD=3.0)在2种检测方法的符合率分别为93.94%、95.24%、100%,在HBsAg ELISA弱反应性标本中,2方法的符合率随S/CO值的增大而增高(0%~90%),灰区标本未检出核酸阳性,而抗-HCV和抗-HIV的弱反应性标本(OD〈3.0)的符合率均为0%。结论减掉1遍ELISA对HBsAg和抗-HCV的反应性比率没有明显的影响,而显著降低了抗-HIV的反应性比率,处于强阳性水平时,ELISA方法的检测结果与NAT符合率较高;ELISA弱反应性标本中2方法的符合率较低,减掉1遍ELISA对检测试剂和人员均提出了更高的要求。 Objective To compare, the reactivity ratio of HBsAg, anti-HCV and anti-HIV before and after reduction of the previous two parallel serological tests into one;and to calculate the coincidence rate between the methods of ELISA and NAT to explore the effect of applying the new model. Methods From January 1 2013 to June 13 2013 using NAT combined with two parallel serologic tests we screened 42 147 donations ;while from June 14th to December 3lst using NAT combined with one serologic test we screened 55 924 specimens in Qingdao blood center. We compared the reactivity ratio of HBsAg, anti-HCV and anti-HIV before and after the changing of screening models, and calculated the coincidence rate of reactive samples between the methods of ELISA and NAT in new mode. Results There was no Significant difference between two par- allel serologic tests and one serologic testing in reactivity ratio of HBsAg and anti HCV ( P 〉0. 05) and the reactivity ratio of anti-HIV were signifieandy lower than that of NAT combined With two parallel serologic tests ( P 〈 0. 05 ). The false positive rate of anti2HIV was 75%. We detected atotal of 217 ELISA reactive specimens,the coincidence rate of ELISA and NAT in strong reactive samples (OD = 3.0) were 93.94% (HBV) ,95.24%, ( HCV ), and 100% ( HIV ), respectively. The coinci- dence rate (0% r-90% ) increased along with the value of S/CO in HBsAg ELISA weak reactive samples. NAT positive sam- pie was not found in ELI.SA gray zone samples. Coincidence rate of anti-HCV and anti-HIV in weak reactive samples ( OD 〈 3.0) was 0%. Conclusion Reducing the previous two' parallel serologic tests into one has no obvious influence on reactivity ratio of HBsAg and anti-HCV, but decreases the reactivity ratio of anti-HIV significantly. Coincidence rate Of ELISA and NAT is high in strong reactive samples,but lown Weakreactive sampleS. The reduction of one round ELISA test puts forward to higher requirements ofreagents and personnel.
机构地区 青岛市中心血站
出处 《中国输血杂志》 CAS CSCD 北大核心 2014年第9期920-922,共3页 Chinese Journal of Blood Transfusion
基金 卫生部部署(管)医疗机构临床学科重点项目建设专项基金(201002005)
关键词 ELISA NAT 无偿献血 HBV HCV HIV ELISA NAT Blood donation HBV HEV HIV
  • 相关文献

参考文献12

  • 1Allain JP.Genomic screening for blood-borne viruses in transfusion settings.Clin Lab Haematol,2000,22(1):1-10. 被引量:1
  • 2Busch MP,Kleinman SH,Jackson B,et al.Nucleic acid amplification testing of blood donors for transfusion transmitted infectious diseases.Transfusion,2000,40(2):143-159. 被引量:1
  • 3Mine H,Emura H,Miyamoto M,et al.High throughout screening of16 million serologically negative bloods donors for hepatitis B virus,and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.J Virol Methods,2003,112(1-2):145-151. 被引量:1
  • 4Kleinman SH,Kuhns MC,Todd DS,et al.Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc:implications for transfusion transmission and donor screening.Transfusion,2003,43(6):696-704. 被引量:1
  • 5Jarvis L,Becker J,Tender A,et al.Evaluation of the Roche cobas s201system and cobas TaqScreen multiplex test for blood screening:a European multicenter study.Transfusion,2008,48(9):1853-1861. 被引量:1
  • 6Margaritis AR,Brown SM,Seed CR,et al.Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.Transfusion,2007,47(10):1783-1793. 被引量:1
  • 7何亚琴,张建伟,杨爱龙,濮云峰,庄华.核酸检测技术在常州地区献血筛查中的应用[J].中国输血杂志,2011,24(7):560-562. 被引量:55
  • 8冯秋霞,许雷,杨忠思,刘丽,赵林.青岛地区核酸检测在血液筛查中的应用研究[J].中国输血杂志,2013,26(7):632-634. 被引量:18
  • 9张妍,朱海峰,孙波,曹磊,陈富强,王静.核酸检测技术在血液筛查中的应用及分析[J].中国输血杂志,2012,25(12):1298-1300. 被引量:50
  • 10Wong L,Lam S,Teo D.Overview of nucleic acid testing(NAT)on blood donation in Singapore.Vox Sang,2005,89(S2):19. 被引量:1

二级参考文献39

  • 1任芙蓉,刘长利,吕秋霜,李慧,张评,高东英,高国静,马国栋,赵海燕,庄辉.病毒核酸检测在献血者血液筛查中的应用[J].中华检验医学杂志,2004,27(9):596-599. 被引量:46
  • 2孙康德,黄永华,虞中敏,沈小韵,顾文莉.三种不同试剂检测丙型肝炎病毒抗体的比较[J].检验医学,2005,20(1):48-48. 被引量:8
  • 3王良华,邬旭群,鲍自谦,陈云龙,叶贤林,尚桂芳,杨立新.不同ELISA试剂HBsAg初复检结果的比较[J].中国输血杂志,2007,20(2):124-125. 被引量:13
  • 4中华人民共和国国家质量监督检验检疫总局.GB18467-2001献血者健康检查要求.2001 被引量:9
  • 5GB18467-2001,献血者健康检查要求.2002-03-01. 被引量:2
  • 6Gallarda JL, Dragon E. Blood screening by nucleic acid amplification technology:current issues, future challenges. Mol Diag,2000,5 (1) :11-12. 被引量:1
  • 7Meng Q, Wong C, Rangaehari A, et al. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA,and human immunodefieieney virus type 1RNA. J Clin Microbio1,2001,39 ( 8 ) :2937-2945. 被引量:1
  • 8Phikulsod S, Oota S, Tirawatnapong T, et al. Working group for NAT study in Thai blood donations. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion. 2009,49(6) :1126-1135. 被引量:1
  • 9Roth WK. NAT and viral safety in blood t ransfilsion. Vox Sang, 2000,78( Suppl 2) :257. 被引量:1
  • 10Margaritis AR,Brown SM,Seed CR,et al.Comparison of two auto-mated nucleic acid testing systems for simultaneous detection of hu-man immunodeficiency virus and hepatitis C virus RNA and hepati-tis B virus DNA.Transfusion.2007,47(10):1783-1793. 被引量:1

共引文献115

同被引文献72

  • 1任芙蓉,王憬惺,赵海燕,文国新,张远志,姚富柱,高国静,严力行,江朝富,白旭华,美黑丽.铁木尔,涂源泉,朱发明,郑优荣,崔莉,龚晓燕,吕秋霜,刘长利,郑鹏,NESS Paul,SHAN Hua.我国5城市合格献血者血液HIV及HCV残余风险研究[J].中国输血杂志,2007,20(6):469-475. 被引量:66
  • 2Chow EP, Lau JT, Zhuang X, et al. HIV prevalence trends, risky behaviours, and governmental and community responses to the epi- demic among men who have sex with men in China. Biomed Res Int,2014,2014:607261. 被引量:1
  • 3Lu J, Xu J, Reilly RH, et al. The proportion and trend of human immunodeficiency virus infections associated with men who havesex with men from Chinese voluntary blood donors: a systematic re- view and meta-analysis. Transfusion, 2015, 55 (3) :576-585. 被引量:1
  • 4国家卫生和计划生育委员会.关于做好血站核酸检测工作的通知.国卫办医发[2015]11号. 被引量:1
  • 5Li L, Xu T, Yang T, et al. Estabilishing a reentry procedure for human immunodefieiency virus screening-reactive donors in China. Transfusion ,2016,56 ( 1 ) : 195-202. 被引量:1
  • 6Delage G, Myhal G, Gr6goire Y, et al. Donors' psychological re- actions to deferral following false-positive screening test results. ~rox Sang,2014,107(2) :132-139. 被引量:1
  • 7Kumar RL, Gupta SL, Kaur A, et al. Individual donor-nucleic acid testing for human immunodeficiency virus-l, hepatitis C virus and hepatitis B virus and its role in blood safety. Asian J Transfus Sci,2015,9(2) :199-202. 被引量:1
  • 8Dodd RY, Aberle-Grasse JM, Stramer SL, et al. The yield of nu- cleic acid testing (NAT) for HIV and HCV RNA in a population of U.S. voluntary donors: relationship to contemporary measures of incidence (abstract). Transfusion,2000, 40(8):975-979. 被引量:1
  • 9卫生部传染病标准专业委员会.WS293-2008艾滋病和艾滋病病毒感染诊断标准.2008-02-28. 被引量:1
  • 10刘国英,邢培清,王莉,刘玉振.郑州市无偿献血者HIV流行病学调查[J].中国输血杂志,2010,23(2):135-136. 被引量:65

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部